Comorbid conditions are a risk for osteonecrosis of the jaw unrelated to antiresorptive therapy

Kenneth E. Fleisher, Malvin N. Janal, Nicole Albstein, James Young, Vanessa Bikhazi, Shlomit Schwalb, Mark Wolff, Robert S. Glickman

Research output: Contribution to journalArticle

Abstract

Objective: Osteonecrosis of the jaw (ONJ) is commonly associated with antiresorptive therapy. There have been numerous reports of ONJ unrelated to antiresorptive therapy (ONJuat), confounding risk assessment. This study aimed to determine if ONJuat is associated with one or more particular comorbidities. Study Design: This was a retrospective case-control study of patients with ONJuat and delayed healing (DH). Each case was matched for patient age and gender, as well as location of ONJuat or DH lesion to a control patient who had a history of dentoalveolar surgery with uneventful healing and no history of antiresorptive therapy. Comorbidity data included medical conditions and smoking. Results: Of the 92 patients identified, 67 (73%) met the criteria for ONJuat and 25 (27%) for DH. The most common trigger for ONJ and DH was extraction (50%). The presence of any comorbidity (i.e., at least 1) was more prevalent in ONJuat than among controls (P = .04), and there were more comorbidities in patients with ONJuat and DH than in controls [M(SD) = 1.94 (1.2) and 2.0 (1.3) vs 1.26 (0.89); both P < .001]. Conclusions: ONJ and DH are not limited to patients with a history of antiresorptive therapy. More comorbidities may signal increased risk for ONJuat and DH.

Original languageEnglish (US)
JournalOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Osteonecrosis
Jaw
Comorbidity
Therapeutics
Case-Control Studies
Smoking

ASJC Scopus subject areas

  • Surgery
  • Oral Surgery
  • Pathology and Forensic Medicine
  • Dentistry (miscellaneous)
  • Radiology Nuclear Medicine and imaging

Cite this

Comorbid conditions are a risk for osteonecrosis of the jaw unrelated to antiresorptive therapy. / Fleisher, Kenneth E.; Janal, Malvin N.; Albstein, Nicole; Young, James; Bikhazi, Vanessa; Schwalb, Shlomit; Wolff, Mark; Glickman, Robert S.

In: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 01.01.2018.

Research output: Contribution to journalArticle

@article{fe97e273afab4717b6dc0e3bcb21c47d,
title = "Comorbid conditions are a risk for osteonecrosis of the jaw unrelated to antiresorptive therapy",
abstract = "Objective: Osteonecrosis of the jaw (ONJ) is commonly associated with antiresorptive therapy. There have been numerous reports of ONJ unrelated to antiresorptive therapy (ONJuat), confounding risk assessment. This study aimed to determine if ONJuat is associated with one or more particular comorbidities. Study Design: This was a retrospective case-control study of patients with ONJuat and delayed healing (DH). Each case was matched for patient age and gender, as well as location of ONJuat or DH lesion to a control patient who had a history of dentoalveolar surgery with uneventful healing and no history of antiresorptive therapy. Comorbidity data included medical conditions and smoking. Results: Of the 92 patients identified, 67 (73{\%}) met the criteria for ONJuat and 25 (27{\%}) for DH. The most common trigger for ONJ and DH was extraction (50{\%}). The presence of any comorbidity (i.e., at least 1) was more prevalent in ONJuat than among controls (P = .04), and there were more comorbidities in patients with ONJuat and DH than in controls [M(SD) = 1.94 (1.2) and 2.0 (1.3) vs 1.26 (0.89); both P < .001]. Conclusions: ONJ and DH are not limited to patients with a history of antiresorptive therapy. More comorbidities may signal increased risk for ONJuat and DH.",
author = "Fleisher, {Kenneth E.} and Janal, {Malvin N.} and Nicole Albstein and James Young and Vanessa Bikhazi and Shlomit Schwalb and Mark Wolff and Glickman, {Robert S.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.oooo.2018.09.012",
language = "English (US)",
journal = "Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology",
issn = "2212-4403",
publisher = "Elsevier USA",

}

TY - JOUR

T1 - Comorbid conditions are a risk for osteonecrosis of the jaw unrelated to antiresorptive therapy

AU - Fleisher, Kenneth E.

AU - Janal, Malvin N.

AU - Albstein, Nicole

AU - Young, James

AU - Bikhazi, Vanessa

AU - Schwalb, Shlomit

AU - Wolff, Mark

AU - Glickman, Robert S.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective: Osteonecrosis of the jaw (ONJ) is commonly associated with antiresorptive therapy. There have been numerous reports of ONJ unrelated to antiresorptive therapy (ONJuat), confounding risk assessment. This study aimed to determine if ONJuat is associated with one or more particular comorbidities. Study Design: This was a retrospective case-control study of patients with ONJuat and delayed healing (DH). Each case was matched for patient age and gender, as well as location of ONJuat or DH lesion to a control patient who had a history of dentoalveolar surgery with uneventful healing and no history of antiresorptive therapy. Comorbidity data included medical conditions and smoking. Results: Of the 92 patients identified, 67 (73%) met the criteria for ONJuat and 25 (27%) for DH. The most common trigger for ONJ and DH was extraction (50%). The presence of any comorbidity (i.e., at least 1) was more prevalent in ONJuat than among controls (P = .04), and there were more comorbidities in patients with ONJuat and DH than in controls [M(SD) = 1.94 (1.2) and 2.0 (1.3) vs 1.26 (0.89); both P < .001]. Conclusions: ONJ and DH are not limited to patients with a history of antiresorptive therapy. More comorbidities may signal increased risk for ONJuat and DH.

AB - Objective: Osteonecrosis of the jaw (ONJ) is commonly associated with antiresorptive therapy. There have been numerous reports of ONJ unrelated to antiresorptive therapy (ONJuat), confounding risk assessment. This study aimed to determine if ONJuat is associated with one or more particular comorbidities. Study Design: This was a retrospective case-control study of patients with ONJuat and delayed healing (DH). Each case was matched for patient age and gender, as well as location of ONJuat or DH lesion to a control patient who had a history of dentoalveolar surgery with uneventful healing and no history of antiresorptive therapy. Comorbidity data included medical conditions and smoking. Results: Of the 92 patients identified, 67 (73%) met the criteria for ONJuat and 25 (27%) for DH. The most common trigger for ONJ and DH was extraction (50%). The presence of any comorbidity (i.e., at least 1) was more prevalent in ONJuat than among controls (P = .04), and there were more comorbidities in patients with ONJuat and DH than in controls [M(SD) = 1.94 (1.2) and 2.0 (1.3) vs 1.26 (0.89); both P < .001]. Conclusions: ONJ and DH are not limited to patients with a history of antiresorptive therapy. More comorbidities may signal increased risk for ONJuat and DH.

UR - http://www.scopus.com/inward/record.url?scp=85056710728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056710728&partnerID=8YFLogxK

U2 - 10.1016/j.oooo.2018.09.012

DO - 10.1016/j.oooo.2018.09.012

M3 - Article

C2 - 30449690

AN - SCOPUS:85056710728

JO - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

JF - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

SN - 2212-4403

ER -